Abstract
Recent studies suggest that 3,4-methylenedioxymethylamphetamine (MDMA), when administered subcutaneously, is toxic to central serotonergic neurons in rats. Because humans typically self-administer this drug orally, we compared this route to the s.c. route of administration. Orally administered MDMA produced a dose-related depletion of serotonin comparable to that produced by the s.c. route. These findings suggest that MDMA, when given orally, retains its neurotoxic activity and that humans using MDMA may be at risk for developing a persistent depletion of brain serotonin.
Original language | English (US) |
---|---|
Pages (from-to) | 141-144 |
Number of pages | 4 |
Journal | Brain research |
Volume | 447 |
Issue number | 1 |
DOIs | |
State | Published - Apr 26 1988 |
Keywords
- 3,4-Methylenedioxymethylamphetamine
- Amphetamine analog
- Neurotoxicity
- Route of administration
- Serotonin
ASJC Scopus subject areas
- Neuroscience(all)
- Molecular Biology
- Clinical Neurology
- Developmental Biology